Finance entity

ResMed

Company RMD

Of the tracked stories, 1 of 2 also mention AMP, the most common co-covered peer. That works out to roughly 0.6 stories per week across a 23-day span. Each story carries 2.5 original sources on average, compared with 3.3 for the broader beat in this window.

Last mentioned: Aug 17, 2026

Entity pulse

Recent coverage · ResMed

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about ResMed

Of the tracked stories, 1 of 2 also mention AMP, the most common co-covered peer. That works out to roughly 0.6 stories per week across a 23-day span. Each story carries 2.5 original sources on average, compared with 3.3 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.2 for that window. Coverage clusters in earnings, which accounts for 1 of those 2, with the remainder spread across 1 other category. ResMed appears in 2 tracked Finance stories published from July 10, 2026 through August 1, 2026.

Stories tracked
2
Per week
0.6
Sources per story
2.5

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 367 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering ResMed. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning ResMed 2

ResMed is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.